✦ LIBER ✦

361 Dexverapamil to overcome anthracycline-resistance in advanced breast cancer

✍ Scribed by N. Kröger; M. Lehnert; K. Mross; F. Gieseking; B. Thürlimann; F. Schüller; H. Kupper; D.K. Hossfeld

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dexverapamil to overcome epirubicin resi

✍ B. Thürlimann; N. Kröger; J. Greiner; K. Mross; J. Schüller; E. Schernhammer; K. 📂 Article 📅 1995 🏛 Springer-Verlag 🌐 English ⚖ 468 KB

A phase II study of paclitaxel in advanc

✍ G. Fountzilas; A. Athanassiades; T. Giannakakis; D. Bafaloukos; K. Karakousis; N 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 607 KB

Docetaxel and cisplatin combination chem

✍ Hailin Xiong; Zhujun Liu; Xin Cheng; Kai Li 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 334 KB

Evolving strategies to overcome endocrin

✍ Hubalek, Michael; Brunner, Christine; Marth, Christian 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 633 KB

Impact, mechanisms, and novel chemothera

✍ Edith A. Perez 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 204 KB

E11. Endocrine resistance in breast canc

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 121 KB